Literature DB >> 35921960

Controlling pallidal oscillations in real-time in Parkinson's disease using evoked interference deep brain stimulation (eiDBS): Proof of concept in the human.

David Escobar Sanabria1, Joshua E Aman2, Valentina Zapata Amaya2, Luke A Johnson2, Hafsa Farooqi2, Jing Wang2, Meghan Hill2, Remi Patriat3, Kelly Sovell-Brown2, Gregory F Molnar2, David Darrow4, Robert McGovern4, Scott E Cooper2, Noam Harel3, Colum D MacKinnon2, Michael C Park4, Jerrold L Vitek5.   

Abstract

Approaches to control basal ganglia neural activity in real-time are needed to clarify the causal role of 13-35 Hz ("beta band") oscillatory dynamics in the manifestation of Parkinson's disease (PD) motor signs. Here, we show that resonant beta oscillations evoked by electrical pulses with precise amplitude and timing can be used to predictably suppress or amplify spontaneous beta band activity in the internal segment of the globus pallidus (GPi) in the human. Using this approach, referred to as closed-loop evoked interference deep brain stimulation (eiDBS), we could suppress or amplify frequency-specific (16-22 Hz) neural activity in a PD patient. Our results highlight the utility of eiDBS to characterize the role of oscillatory dynamics in PD and other brain conditions, and to develop personalized neuromodulation systems.
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Closed-loop deep brain stimulation; Neural oscillations; Parkinson's disease; Real-time neural control

Mesh:

Year:  2022        PMID: 35921960     DOI: 10.1016/j.brs.2022.07.047

Source DB:  PubMed          Journal:  Brain Stimul        ISSN: 1876-4754            Impact factor:   9.184


  1 in total

1.  The impact of pulse timing on cortical and subthalamic nucleus deep brain stimulation evoked potentials.

Authors:  Brett A Campbell; Leonardo Favi Bocca; David Escobar Sanabria; Julio Almeida; Richard Rammo; Sean J Nagel; Andre G Machado; Kenneth B Baker
Journal:  Front Hum Neurosci       Date:  2022-09-20       Impact factor: 3.473

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.